Search results
Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 2 months agoAbbVie Inc's robust immunology and oncology portfolio drives its competitive edge. Patent expirations and biosimilar competition present significant...
AbbVie (ABBV) Buys Parkinson's Disease Treatment Maker
Zacks via Yahoo Finance· 7 months agoAbbVie's (ABBV) buyout of Mitokinin, which is making a novel treatment for Parkinson's Disease (PD),...
Insider Sell: EVP Nicholas Donoghoe Sells Shares of AbbVie Inc
GuruFocus.com via Yahoo Finance· 4 months agoNicholas Donoghoe, EVP, CHIEF BUS/STRAT OFFICER of AbbVie Inc (NYSE:ABBV), has sold 2,912 shares of...
AbbVie (ABBV) Tops Q1 Earnings Estimates
Zacks via Yahoo Finance· 2 years agoAbbVie (ABBV) delivered earnings and revenue surprises of 0.32% and 0.09%, respectively, for the quarter ended March 2022. Do the numbers hold clues to...
Drugmakers scout for deals, ramp up research spending
Reuters via Yahoo Finance· 1 year agoDrugmakers including Merck & Co, AstraZeneca Plc and AbbVie Inc said on Thursday they are open to...
Which Stock Is More Likely to Double Your Money First: Moderna or AbbVie?
Motley Fool· 2 years agoTake the case of AbbVie (NYSE: ABBV) and Moderna (NASDAQ: MRNA). AbbVie spun off from Abbott...
AbbVie Stock’s Healthy Yield Makes it a High-Conviction Holding
InvestorPlace via Yahoo Finance· 2 years agoHeadquartered in Illinois, AbbVie (NYSE:ABBV) is a well-respected pharmaceutical businesses with a broad range of medical treatments and solutions. If you’re going to pick a pharmaceutical-market ...
10 Highest Dividend Stocks on Cash App
Insider Monkey via Yahoo Finance· 4 months agoIn this article, we discuss 10 highest dividend stocks on Cash App. You can skip our detailed analysis of investing through Cash App and the previous...
11 Best Psychedelic Stocks to Buy in 2024
Insider Monkey via Yahoo Finance· 4 months agoIn this article, we discuss 11 of the best psychedelic stocks to buy in 2024. If you want to see more stocks in this selection, check out 5 Best...
US FDA declines to approve Eli Lilly's bowel disease drug
Reuters via Yahoo News· 1 year agoThe agency's decision puts Lilly further behind in its quest to enter the nearly $20 billion market,...
